UK drug delivery specialist SkyePharma has signed an agreement with
India's Dr Reddy's Laboratories for a feasibility study of an
unnamed product using two of SkyePharma's proprietary drug delivery
systems.
SkyePharma will shortly sign up a marketing partner for its
improved formulation of the local anaesthetic bupivacaine, a
product which the UK-based drug delivery company says is one of the
most important products in its pipeline.
Drug delivery specialist SkyePharma has decided to press ahead with
the development of new drug products based on an encapsulation
technology developed by fellow UK company Micap.
UK drug delivery company SkyePharma expects to make a loss in 2003,
a disappointing result given that it chalked up its first
profitable year just a year earlier, and will cut 10 per cent of
its workforce as a result.
A new formulation of GlaxoSmithKline's Parkinson's disease drug
Requip (ropinirole), developed with UK drug delivery specialist
SkyePharma, has entered Phase III testing.
UK company SkyePharma is expecting to achieve turnover of £100
million (€139m) in 2003, which would represent a rise of around 40
per cent over last year. However, the company has warned that the
lion's share of this total would...